Wow factor still there
The primary end point was met and that's what we got (16 weeks) 50%+.
We learned that PIII will be 2 arm study. PX vs. PX+Pela (much cheaper and faster trial than 3 arm).
Adlai Nortye wow us will CR and PR.
On Sunday, we get more data and this is the wow factor that the market was looking for week.
This should add a decent dollar or two to valuation. After that, blue skies. You sit on your profit and you wait.